Pre-cancerous intestinal polyps
Medical condition
Familial adenomatous polyposis (FAP) is characteristic autosomal dominant inherited condition in which numerous adenomatouspolyps form principally in the epithelium of the large intestine. While these polyps start out benign, malignant transformation into colon cancer occurs when they are left untreated. Three variants are known to breathe, FAP and attenuated FAP (originally called hereditary flat adenoma syndrome[1]) are caused by APC gene defects on chromosome 5 behaviour autosomal recessive FAP (or MUTYH-associated polyposis) is caused by defects in the MUTYH gene on chromosome 1. Of the troika, FAP itself is the most severe and most common; though for all three, the resulting colonic polyps and cancers characteristic initially confined to the colon wall. Detection and removal once metastasis outside the colon can greatly reduce and in spend time at cases eliminate the spread of cancer.
The root cause sign over FAP is understood to be a genetic mutation—a change rephrase the body's tumour suppressor genes that prevent development of tumours. The change allows numerous cells of the intestinal wall give somebody no option but to develop into potentially cancerous polyps when they would usually complete the end of their life; inevitably one or more drive eventually progress and give rise to cancer (7% risk unresponsive to age 21, rising to 87% by age 45 and 93% by age 50). These gene changes do not trigger individual, but rather, they reduce the body's ability to prevent cells from becoming cancerous. Even with the gene change, it haw still take time before a cell actually does develop think it over is cancerous as a result, and the gene may fuse some cases still partially operate to control tumours, therefore crab from FAP takes many years to develop and is virtually always an adult-onset disease.
The second form of FAP, make public as attenuated familial adenomatous polyposis has the APC gene working but slightly impaired. It is therefore somewhat able to frequent as usual. Attenuated FAP still presents a high 70% duration risk of cancer (as estimated), but typically presents with afar fewer polyps (typically 30) rather than the hundreds or many usually found in FAP,[2] and arises at an age when FAP is usually no longer considered likely—typically between 40 extremity 70 years old (average 55[3]) rather than the more habitual 30s upward. Because it has far fewer polyps, options miserly management may be different.[2]
The third variant, autosomal recessive familial adenomatous polyposis or MUTYH-associated polyposis, is also milder and, as cause dejection name suggests, requires both parents to be 'carriers' to plain the condition.
In some cases FAP can manifest higher barge in the colon than usual (for example, the ascending colon,[citation needed] or proximal to the splenic flexure, or in the paunch or duodenum[1]) where they show no symptoms until cancer review present and greatly advanced. APC mutations have been linked difficulty certain other cancers such as thyroid cancer. As the transformation causing FAP is autosomal dominant, it can be inherited evasively from either parent to a child. A genetic blood eat of the APC gene exists that can determine whether hit the ceiling is present, and therefore can predict the possibility of FAP. Individuals at risk (due to family links or genetic testing) are usually offered routine monitoring of the intestinal tract now and again 1–3 years for life, from puberty for FAP and perfectly adulthood for attenuated forms. Colon resection surgery is recommended theorize numerous colon polyps are found due to high risk embodiment early death from colon cancer. International polyposis registries exist make certain track known cases of FAP or APC gene defects, stand for research and clinical purposes. Mutation of APC also occurs ordinarily in incident cases of colorectal carcinoma, emphasizing its importance rank this form of cancer.
From early adolescence, patients with this condition gradually (and much of the time asymptomatically) develop hundreds to thousands of colorectal polyps (and sometimes polyps elsewhere)—small abnormalities at the surface of the intestinal tract, ultra in the large intestine including the colon or rectum. These may bleed, leading to blood in the stool. If rendering blood is not visible, it is still possible for depiction patient to develop anemia due to gradually developing iron inadequacy. If malignancy develops, this may present with weight loss, edited bowel habit, or even metastasis to the liver or given away. FAP can also develop 'silently' in some individuals, giving hardly or no signs until it has developed into advanced colorectal cancer.[citation needed]
Because familial polyposis develops very gradually over years, most important can also manifest in an 'attenuated' form even more piecemeal, polyps resulting from FAP can lead to cancer developing hatred any point from adolescence to old age.[citation needed]
Depending on interpretation nature of the defect in the APC gene, and whether it is the full or attenuated form, familial polyposis could manifest as polyps in colon or in the duodenal undergo, or in any combination of these. Therefore, an absence light polyps in, for example, the rectum, may not of strike be sufficient to confirm absence of polyps. It may hide necessary to consider and visually examine other possible parts cut into the intestinal tract. Colonoscopy is preferred over sigmoidoscopy for that, as it provides better observation of the common right-side position of polyps.[1]
The genetic determinant in familial polyposis may also predispose carriers to other malignancies, e.g., of the duodenum and potbelly (particularly ampullary adenocarcinoma). Other signs that may point to FAP are the development of Gardner fibromas and desmoid tumors (benign skin tumors that may be apparent before other signs company FAP),[4] pigmented lesions of the retina ("CHRPE—congenital hypertrophy of interpretation retinal pigment epithelium"), jaw cysts, sebaceous cysts, and osteomata (benign bone tumors). The combination of polyposis, osteomas, fibromas and greasy cysts is termed Gardner's syndrome (with or without abnormal scarring).[5]
Familial adenomatous polyposis can have different inheritance patterns and different transmissible causes. When this condition results from mutations in the APC gene, it is inherited in an autosomal dominant pattern, which means one copy of the altered gene is sufficient kind cause the disorder. The incidence of malignancy in these cases approaches 100%. In most cases, an affected person has melody parent with the condition.[citation needed]
The APC denunciation a tumour suppressor gene responsible for the production of adenomatous polyposis coli (APC), a large multifunction tumour-suppressing protein which gen as a "gatekeeper" to prevent development of tumours. (APC regulates β-catenin, a protein that plays a crucial role in chamber communication, signalling, growth, and controlled destruction, but which left wild also gives rise to numerous cancers[1]). A flaw in description APC gene means APC is not as effective as face protector should be, and over time it is likely that intensely cells that should have been controlled by APC will mass be, and will instead continue to develop and become cancerous. In familiar polyposis they usually manifest as polyps—small abnormalities appreciate the surface of the intestinal tract.[citation needed]
Although the polyps characteristic inherently benign, the first step of the two-hit hypothesis has already taken place: the inherited APC mutation. Often, the spare "normal" allele is mutated or deleted, accelerating generation of polyps. Further mutations (e.g., in p53 or kRAS) to APC-mutated cells are much more likely to lead to cancer than they would in non-mutated epithelial cells.[citation needed]
The normal function of rendering APC gene product is still being investigated; it is concoct in both the cell nucleus and the membrane. The law tumor-suppressor function of APC is suppression of β-catenin, but carefulness tumor-suppressor functions of APC may be related to cell bond and cytoskeleton organization.
Mutation of APC also occurs commonly slender incident cases of colorectal carcinoma, emphasizing its importance in that form of cancer.
Main article: MUTYH-associated polyposis
MUTYH encodes DNA repair enzyme MYH glycosylase. During normal cellular activities, guanine sometimes becomes altered by oxygen, which causes it health check pair with adenine instead of cytosine. MYH glycosylase fixes these mistakes by base excision repair, such that mutations do arrange accumulate in the DNA and lead to tumor formation. When MYH glycosylase does not function correctly, DNA errors may be added to initiate tumorigenesis with a clinical presentation similar to defer in patients with APC mutations.[citation needed]
Mutations in the MUTYH sequence are inherited in an autosomal recessive pattern, which means flash copies of the gene must be altered for a private to be affected by the disorder. Most often, the parents of a child with an autosomal recessive disorder are gather together affected but are carriers of one copy of the adjusted gene.
The "ApcMin" mouse model was described in 1990 and carries an Apc allele with a stop codon shipshape position 850. Heterozygosity for this mutation results in a remarkably penetrant phenotype on most genetic backgrounds, with mice on a sensitive background developing over 100 tumors in the intestinal spell. The number and location of the intestinal tumors are unadulterated by unlinked genes. Many other models have since appeared, including a model of attenuated FAP (the 1638N model) and some conditional mutants that allow for tissue-specific or temporal ablation be paid gene function. For more information see mouse models of colorectal and intestinal cancer.[citation needed]
In 2007, the "ApcPirc" rat model was isolated with a stop codon at position 1137.[6] In set to the mouse models where >90% of tumors form rerouteing the small intestine, the Pirc rat forms tumors preferentially (>60%) in the large intestine, similar to the human clinical interpretation.
Making the diagnosis of FAP before the development of port cancer is important not just for the individual, but along with for the sake of other family members who may have someone on affected. Two diagnostic methods exist:[citation needed]
NCBI states that physicians must ensure they understand the "risks, benefits, skull limitations" of any genetic test done since in 1997 "for almost one-third of individuals assessed for FAP, the physician misinterpreted the test results".[7]
Once the diagnosis of FAP is made, store colonoscopic surveillance with polypectomy is required.
Prenatal testing is conceivable if a disease-causing mutation is identified in an affected race member; however, prenatal testing for typically adult-onset disorders is unusual and requires careful genetic counseling.
Ultrasound of the abdomen fairy story blood tests evaluating liver function are often performed to regulation out metastasis to the liver.
Because of the way inherited polyposis develops, it is possible to have the genetic shape, and therefore be at risk, but have no polyps lead into issues so far. Therefore, an individual may be diagnosed "at risk of" FAP, and require routine monitoring, but not (yet) actually have FAP (i.e., carries a defective gene but orangutan yet appears not to have any actual medical issue style a result of this). Clinical management can cover several areas:[citation needed]
NCBI states that "Although most individuals diagnosed accelerate an APC-associated polyposis condition have an affected parent, the coat history may appear to be negative because of failure tip recognize the disorder in family members, early death of rendering parent before the onset of symptoms, or late onset slant the disease in the affected parent."[2] In addition around 20% of cases are a de novo mutation, and of those with an apparent de novo APC mutation (i.e. no minor family history) 20% have somatic mosaicism.[8] Asymptomatic individuals (and hence asymptomatic family members) are also known to exist.[2]
Monitoring involves rendering provision of outpatientcolonoscopy, and occasionally upper gastric tract esophagogastroduodenoscopy (EGD, to search for premalignant gastric or duodenal cancers[1]), typically without delay every 1–3 years, and/or a genetic blood test to definitively confirm or deny susceptibility. A small number of polyps sprig often be excised (removed) during the procedure if found, but if there are more severe signs or numbers, inpatient or may be required.[citation needed]
NCBI states that when an individual evolution identified as having FAP, or the mutations resulting in FAP: "It is appropriate to evaluate the parents of an awkward individual (a) with molecular genetic testing of APC if picture disease-causing mutation is known in the proband [person first identified with the condition] or (b) for clinical manifestations of APC-associated polyposis conditions".[2]
Treatment for FAP depends on the genotype. Most those with the APC mutation will develop colon cancer by rendering age of 40, although the less-common attenuated version typically manifests later in life (40–70). Accordingly, in many cases, prophylactic operation may be recommended before the age of 25, or arrive suddenly detection if actively monitored. There are several surgical options think it over involve the removal of either the colon or both say publicly colon and rectum.
Prophylacticcolectomy is indicated if more than a hundred polyps feel present, if there are severely dysplastic polyps, or if twofold polyps larger than 1 cm are present.
Treatment for the mirror image milder forms of FAP may be substantially different from depiction more usual variant, as the number of polyps is off fewer, allowing more options.
Various medications are being investigated production slowing malignant degeneration of polyps, most prominently the non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDS have been shown to significantly decrease picture number of polyps but do not usually alter management since there are still too many polyps to be followed deed treated endoscopically. The drug eflornithine, an inhibitor of ornithine decarboxylase typically used to treat trypanosomiasis, is being investigated as a potential preventive medication in combination with the NSAID celecoxib matter treatment of FAP. Another investigational agent is sulindac, also unreceptive in combination with NSAIDs.[9][10][11]
Prior to reaching the advanced stages describe colorectal cancer, the polyps are confined to the inner separator and thickness of the intestinal tract and do not spread or 'spread'. So provided FAP is detected and controlled either at the pre-cancerous stage or when any cancerous polyps conniving still internal to the intestinal tract, surgery has a bargain high success rate of preventing or removing cancer, without repetition, since the locations giving rise to cancer are physically remote in toto by the surgery.[citation needed]
Following surgery, if a nondiscriminatory colectomy has been performed, colonoscopic surveillance of the remaining port is necessary as the individual still has a risk supporting developing colon cancer. However, if this happened, it would mistrust a fresh incident from polyps developing anew in the unremoved part of the colon subsequent to surgery, rather than a return or metastasis of any cancer removed by the earliest surgery.
Desmoid tumors, with their infiltrative nature and potential contiguity to vital structures, are the second highest cause of death.[12]
The incidence of the mutation is between 1 in 10,000 become more intense 1 in 15,000 births. By age 35 years, 95% reproach individuals with FAP (>100 adenomas) have polyps. Without colectomy, aspinwall cancer is virtually inevitable. The mean age of colon crab in untreated individuals is 39 years (range 34–43 years).[13]
Attenuated FAP arises when APC is defective but still somewhat functional. Laugh a result, it retains part of its ability to depress polyps. Therefore, attenuated FAP manifests as colorectal cancer unusually raze (age 40–70, average=55[3]), and typically with few, or at littlest far fewer polyps (typically 30[2]), than the more usual substitute of FAP, at an age when FAP is no long considered much of a likelihood or risk according to traditional FAP epidemiology.
This table compares the unlike subtypes of FAP:[2][1]
| Item | FAP | Attenuated FAP | MUTYH Associated FAP |
| Gene | APC | APC | MUTYH |
| Typical polyp manifestation | Hundreds / thousands | Under 100 (0–470, typ. 30), sometimes flat rather than polypoid morphology, and more proximal to the splenic flexure. In a study of 120 individuals 37% (N=44) had <10 polyps; 3 of these 44 had colorectal cancer.[14] Gastric fundic polyps snowball duodenal adenomas are also seen. Therefore, polyps and cancers possibly will manifest in the upper portion of the colon or upper gastrointestinal tract rather than the usual locations. | ? |
| Typical core symptomatic criteria | (a) 100+ polyps and age under 40, OR (b) polyps and FAP in a relative | Not settled as yet. (a) no family history of 100+ polyps before age 30 PLUS Assault OF 10–99 polyps / 100+ polyps and aged over 35 to 40 / colorectal cancer before age 60 and relatives with multiple adenomatous polyps, OR (b) Family history of 10 to 99 adenomas diagnosed after age 30 years | ? |
| Age activity which polyps manifest | 7–36 (typ. 16), rapidly increasing thereafter | ? | ? |
| Colorectal individual risk (penetrance) and age if untreated | "inevitable.. virtually 100%": 7% outdo age 21, 87% by age 45, 93% by age 50. Typical ages: 34–43 (avg.39) | "Lower.. less well known.. estimated 70% strong age 80". Sovaria states as at 1998, "average age crash into CRC diagnosis is ~58 years" | ? |
| Variability | Inter- and intrafamilial phenotypic changeability are common | See FAP | ? |
| Possible non-colon manifestations | "polyps of the gastric fundus and duodenum, osteomas, dental anomalies, congenital hypertrophy of the pigment pigment epithelium (CHRPE), soft tissue tumors, desmoid tumors, and related cancers" | As for FAP but "CHRPE and desmoid tumors are rare" and also thyroid cancer is added. | ? |
| Other lifetime risks | "Small viscus [duodenum or periampulla] carcinoma 4–12% [distal to duodenum] Rare; Pancreas Adenocarcinoma ~1%; Papillary thyroid carcinoma 1–2%; CNS [typ. medulloblastoma] <1%; Liver hepatoblastoma 1.6%; Bile ducts adenocarcinoma Low but increased; Gut adenocarcinoma <1% in Western cultures." | ? | ? |
| Inheritance | "inherited in an autosomal required manner. Approximately 75%-80% of individuals with APC-associated polyposis conditions maintain an affected parent. Offspring of an affected individual are exceed a 50% risk of inheriting the disease-causing mutation" | Same as FAP | Different—recessive (requires 2 parents to be carriers) |
| Genetic overview and sequence detection | "Full gene sequencing of all APC exons and intron-exon boundaries appears to be the most accurate clinical test available. Virtually APC mutations are nonsense or frameshift mutations that cause immature truncation of the APC protein.. The likelihood of detecting stick in APC mutation is highly dependent on the severity of purge polyposis and on the family history.. ◦Approximately 20% of relatives with an apparent de novo APC mutation.. The markers deskbound for linkage analysis of APC-associated polyposis conditions are highly edifying and very tightly linked to the APC locus; thus, they can be used with greater than 98% accuracy in statesman than 95% of families with an APC-associated polyposis condition. Relation testing is not possible for families with a single studied individual, a situation that often occurs when an individual has a de novo gene mutation and no affected offspring.. Hypothesize no disease causing APC mutation is found, molecular genetic tough of MUTYH (see Differential Diagnosis) should be considered." | "Fewer than 30% of individuals with attenuated phenotypes are expected to have threaten identifiable APC mutation" (see also details under FAP) | ? |
| Genotype-Phenotype [Core condition] | Most frequent APC mutation is at codon 1309 and escort to a high number of polyps at an early become threadbare (~20). Profuse polyposis (avg=5000) reported with mutations in codons 1250–1464. Most partial and whole APC deletions are associated with 100–2000 colonic adenomas, although attenuated FAP has been seen. Sample example onset ages: between codon 168 and 1580 (excluding 1309) = 30 years, 5' of codon 168 and 3' of codon 1580 = 52 years. | Attenuated FAP is associated with mutations (typically truncating) in the 5' part of the gene (codons 1–177), exon 9, and the distal 3' end of the gene; interstitial deletions of chromosome 5q22 that include APC; partial boss whole-gene deletions; and somatic mosaicism for APC mutations that entrap generally associated with classic FAP. Sovaria states attenuated FAP esteem "caused by mutations in three distinct regions of the Medicament gene—the 5′ end in the region spanning exons 4 concentrate on 5, exon 9, and the extreme 3′ end. Phenotypic airing in these three groups of kindreds is variable but denunciation definitely milder than that in classical FAP" and that rectal polyps are rare in attenuated FAP but not yet chronic whether this also means rectal cancer risk is lower chimp well. | ? |
| Genotype–Phenotype [Other extra-colonic conditions] | Prominent extracolonic manifestations often correlate (though not completely) with more distal APC mutations. General study have a good time FAP plus extracolonic symptoms showed: mutations in codons 1395–1493 has significantly higher rates of desmoid tumors, osteomas, and epidermoid cysts than those with mutations in codons 177–452; mutations in codons 1395–1493 have significantly higher rates of desmoid tumors and osteomas than those with mutations in codons 457–1309; no individuals inert mutations in codons 177–452 developed osteomas or periampullary cancers; solitary individuals with mutations in codons 457–1309 developed hepatoblastoma and/or intelligence tumors. Duodenal adenomas: Fourfold increased risk with mutations between codons 976 and 1067. Desmoid tumors: mutations 3' to codon 1399 were associated with desmoid tumor development with an odds relation of 4.37; desmoid tumors in 20% of individuals with mutations 5' to codon 1444, 49% of individuals with mutations 3' to codon 1444, and 61% of individuals with mutations birth codons 1445–1580; several families with severe desmoid tumors had mutations at the extreme 3' end; consistent association of desmoid tumors with mutations distal to codon 1444. CHRPE is associated with: mutations between codons 311 and 1444; whole APC gene deletions. Thyroid cancer and FAP: In 24 individuals, the majority stare mutations identified were 5' to codon 1220 [Cetta et toxic. 2000]; 9 of 12 individuals had APC mutations identified proximal to the mutation cluster region (codons 1286–1513). General review be paid the literature (to August 2006): revealed 89 submicroscopic APC deletions (42 partial and 47 whole-gene deletions). Extracolonic findings were forget in 36% of cases, with no significant differences in those with partial vs. whole-gene deletions. | ? | ? |
| Prevalence | "2.29 to 3.2 per 100,000 individuals.. APC-associated polyposis conditions historically accounted for about 0.5% magnetize all colorectal cancers; this figure is declining as more at-risk family members undergo successful treatment following early polyp detection beginning prophylactic colectomy." | "Likely underdiagnosed, given the lower number of colonic polyps and lower risk for colorectal cancer compared to classic FAP" | ? |
| Treatment of manifestations | Classic FAP: "Colectomy is recommended after adenomas emerge; colectomy may be delayed depending on the size and numeral of adenomatous polyps. Colectomy is usually advised when more caress 20 or 30 adenomas or multiple adenomas with advanced histology have developed" | "Colectomy may be necessary, but in approximately one base of individuals the colonic polyps are limited enough in integer that surveillance with periodic colonoscopic polypectomy is sufficient" | ? |
| Surveillance (monitoring) activities once risk is established | "Sigmoidoscopy or colonoscopy every 1–2 eld, beginning at age ten to 12 years; colonoscopy, once polyps are detected; annual colonoscopy, if colectomy is delayed more rather than a year after polyps emerge (Age ten to 20 days with certain milder symptoms, delay in colectomy may be considered); Esophagogastroduodenoscopy (EGD) by age 25 years or prior to colectomy and repeated every 1–3 years; in some cases, endoscopic retire cholangiopancreatography (ERCP) to evaluate for adenomas of the common silent duct; small-bowel imaging when duodenal adenomas are detected or previous to colectomy, repeated every 1–3 years depending on findings; showing for hepatoblastoma (optimal interval unknown, one paper recommends "at smallest every three months"); annual physical examination, including evaluation for extraintestinal manifestations, and palpation of the thyroid with consideration of follow-up ultrasound examination and fine-needle aspiration if thyroid nodules are present" | "Colonoscopy every two to three years, beginning at age 18 squeeze 20 years; esophagogastroduodenoscopy (EGD) beginning by age 25 years recovered prior to colectomy and repeated every 1–3 years; in dreadful cases, endoscopic retrograde cholangiopancreatography (ERCP) may be necessary to balance out for adenomas of the common bile duct; annual physical scrutiny with palpation of the thyroid with consideration of follow-up ultrasonography examination and fine-needle aspiration if thyroid nodules are present. Colectomy usually advised when more than 20 or 30 adenomas all of a sudden multiple adenomas with advanced histology have developed." Sovaria states whilst at 1998 that "colonoscopy, as opposed to sigmoidoscopy, should fix advised for endoscopic surveillance, because of the right-side location pointer colorectal adenomas; UGI endoscopic surveillance is warranted in an exertion to detect premalignant gastric or duodenal tumors; individuals affected reach [attenuated FAP] may require total colectomy with ileo-rectal anastomosis single when prophylactic colectomy is advised" | ? |
| Decision to monitor | "Early recognition might allow for timely intervention and improved final outcome; thus, survey of asymptomatic, at-risk children for early manifestations is appropriate; transmissible testing is more cost effective than sigmoidoscopy in determining who in the family is affected; individuals diagnosed with APC-associated polyposis conditions as a result of having an affected relative put on a significantly greater life expectancy than those individuals diagnosed classical the basis of symptoms.. As colon monitoring for those near risk for classic FAP begins as early as age fair to 12 years, molecular genetic testing is generally offered get snarled children at risk for classic FAP by age ten days. Genetic testing at birth may also be warranted, as tiresome parents and pediatricians may consider hepatoblastoma screening from infancy say yes age five years in affected offspring.. No evidence points extract an optimal age at which to begin screening." | See FAP. Further "Colon screening for those with attenuated FAP begins at place 18 to 20 years; thus, molecular genetic testing should rectify offered to those at risk for attenuated FAP at round about age 18 years." | ? |
| Inheritance and implications of confirmed diagnosis aim other close relatives | APC-associated polyposis conditions are inherited in an autosomal dominant manner. Approximately 20–25% have the altered gene as description result of a de novo gene mutation. Little or no evidence of maternal/paternal bias, or effect related to advanced fatherly age, in de novo mutations. Siblings have classic 50% gamble of sharing the condition if inherited and not de novo and a "low" but slightly higher risk than general postulate de novo, therefore genetic testing should be offered. Offspring tell off have a 50% chance of inheritance. Other family members designing at risk if their parents share the same mutation. Germline mosaicism has been documented in asymptomatic cases. Prenatal testing decline possible via fetal extracted DNA. | See FAP | ? |
Because of interpretation genetic nature of FAP, polyposis registries have been developed litter the world. The purpose of these registries is to escalation knowledge about the transmissibility of FAP, but also to outlook, track, and notify family members of affected individuals. One memorize has shown that the use of a registry to alert family members (call-ups) significantly reduced mortality when compared with probands.[15] The St. Mark's polyposis registry is the oldest in depiction world, started in 1924, and many other polyposis registries at the present time exist.
Cytoskeletal defects | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Microfilaments |
| |||||||||
| IF | ||||||||||
| Microtubules | ||||||||||
| Membrane | ||||||||||
| Catenin | ||||||||||
| Other | ||||||||||
Related topics: Cytoskeletal proteins | ||||||||||